title: Kidney toxicogenomics of chronic potassium bromate exposure in f344 male rats.
abstract: BACKGROUND
  Potassium bromate (KBrO3), used in both the food and cosmetics industry, and a drinking water disinfection by-product, is a nephrotoxic compound and rodent carcinogen. To gain insight into the carcinogenic mechanism of action and provide possible biomarkers of KBrO3 exposure, the gene expression in kidneys from chronically exposed male F344 rats was investigated.
  
  
  METHODS
  Male F344 rats were exposed to KBrO3 in drinking water for 52 and 100 wk. Kidneys were removed, frozen, and stored at -80°C, then used for Affymetrix microarray analysis. Gene expression patterns were examined using a non-carcinogenic (20 ppm) and carcinogenic dose (400 ppm) at 52 wk, and compared to 100 wk high dose (400 ppm) and adenoma gene expression.
  
  
  RESULTS
  Statistical analysis revealed 144, 224, 43, and 994 genes out of 15866 from the 52 wk low, 52 wk high, 100 wk high, and adenomas respectively, were differentially expressed when compared to control kidneys. Gene ontology classification of the 52 wk high dose showed alterations of gene transcripts involved in oxidative stress, lipid metabolism, kidney function/ion transport, and cellular function. In a comparison of kidney development gene expression, alterations were seen in the adenomas but not in the 52 wk bromate-treated kidneys. However, the normal kidney from the high dose group resembled the adenoma expression pattern with early kidney development genes being up-regulated and adult phase genes being down-regulated. Moreover, eight genes were identified which could serve as biomarkers of carcinogenic exposure to bromate. The most promising of these was Pendrin, or Slc26a4, a solute carrier of chloride and iodide active in the kidney, thyroid, and inner ear. All these tissues are targets of KBrO3 toxicity. Expression array results were verified with quantitative real-time rtPCR.
  
  
  CONCLUSIONS
  These data demonstrate that the 400 ppm carcinogenic dose of KBrO3 showed marked gene expression differences from the 20 ppm non-carcinogenic dose. Comparison of kidney development gene expression showed that the adenoma patterns were more characteristic of embryonic than adult kidneys, and that the normal kidney from the high dose group resembled the adenoma-like gene expression pattern. Taken together, the analysis from this study identifies potential biomarkers of exposure and illuminates a possible carcinogenic mode of action for KBrO3.
authors: National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711. ; National Exposure Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711.
authors: David R
authors: DR
authors: Geter
authors: William O
authors: WO
authors: Ward
authors: Geremy W
authors: GW
authors: Knapp
authors: Anthony B
authors: AB
authors: Deangelo
authors: Jessica A
authors: JA
authors: Rubis
authors: Russell D
authors: RD
authors: Owen
authors: James W
authors: JW
authors: Allen
authors: Don A
authors: DA
authors: Delker
keywords: biomarker; bromate; disinfection by-product; drinking water; gene expression
references: Res Commun Chem Pathol Pharmacol. 1992 Nov;78(2):211-8
references: 1475527
references: Free Radic Biol Med. 2003 Sep 1;35(5):528-39
references: 12927602
references: J Natl Cancer Inst. 1983 Nov;71(5):965-72
references: 6580498
references: Proc Natl Acad Sci U S A. 2001 May 8;98(10):5649-54
references: 11331749
references: Biochemistry. 1990 Jul 31;29(30):7024-32
references: 2223758
references: Mol Cell Biol. 1996 Jun;16(6):2570-8
references: 8649364
references: Oncogene. 2002 Apr 25;21(18):2829-39
references: 11973642
references: Genome Biol. 2001;2(8):RESEARCH0032
references: 11532216
references: Bioinformatics. 2001 Jun;17(6):509-19
references: 11395427
references: Cancer Sci. 2004 May;95(5):393-8
references: 15132765
references: Cancer Lett. 1999 Jan 29;135(2):181-8
references: 10096427
references: Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):31-6
references: 11134512
references: Sci Total Environ. 1985 Dec;47:299-315
references: 4089604
references: Toxicol Pathol. 1998 Sep-Oct;26(5):587-94
references: 9789944
references: IARC Monogr Eval Carcinog Risk Chem Hum. 1986;40:207-20
references: 3473002
references: Chem Res Toxicol. 2001 Jun;14(6):678-85
references: 11409938
references: Hear Res. 2004 Sep;195(1-2):9-16
references: 15350275
references: FASEB J. 2004 Jan;18(1):62-9
references: 14718387
references: Toxicol Pathol. 1998 Nov-Dec;26(6):724-9
references: 9864088
references: Oncogene. 2001 May 31;20(25):3290-300
references: 11423978
references: Oncogene. 2001 Feb 15;20(7):879-84
references: 11314022
references: Redox Rep. 1999;4(6):263-9
references: 10772065
references: Prog Lipid Res. 1993;32(1):71-110
references: 8415800
references: Carcinogenesis. 1995 Feb;16(2):335-42
references: 7859366
references: Toxicol Appl Pharmacol. 2000 Dec 15;169(3):205-21
references: 11133343
references: Toxicology. 1998 Mar 13;126(2):93-102
references: 9620541
references: Am J Physiol Renal Physiol. 2001 Feb;280(2):F356-64
references: 11208611
references: FEBS Lett. 2000 May 4;473(1):47-52
references: 10802057
references: J Natl Cancer Inst. 1986 Oct;77(4):977-82
references: 3463824
references: Mutat Res. 1998 Jun;410(3):271-90
references: 9630671
references: Environ Health Perspect. 1986 Nov;69:221-35
references: 3816726
references: Jpn J Cancer Res. 1987 Apr;78(4):358-64
references: 3108216
references: J Biol Chem. 2000 Feb 25;275(8):5958-65
references: 10681589
references: Kidney Int. 2000 Feb;57(2):464-75
references: 10652023
references: Natl Cancer Inst Carcinog Tech Rep Ser. 1976 Mar;1976:1-60
references: 25299382
references: Environ Health Perspect. 1990 Jul;87:309-35
references: 2269236
references: Toxicology. 2006 Apr 17;221(2-3):154-7
references: 16473452
references: Arch Environ Contam Toxicol. 2000 Jan;38(1):1-6
references: 10556365
references: Nature. 1991 Jan 31;349(6308):431-4
references: 1992344
references: Toxicology. 2006 Apr 17;221(2-3):158-65
references: 16442688
references: Kidney Int. 1998 Jun;53(6):1661-72
references: 9607198
references: Nat Genet. 1999 Apr;21(4):440-3
references: 10192399
references: Biochem Soc Symp. 2004;(71):157-76
references: 15777020
references: J Histochem Cytochem. 2003 Feb;51(2):167-73
references: 12533525
references: Curr Opin Nephrol Hypertens. 2005 Mar;14(2):149-53
references: 15687841
references: Arch Toxicol. 1998 Apr;72(5):264-9
references: 9630011
references: Br J Cancer. 2005 Jul 11;93(1):144-51
references: 15942636
references: Hepatology. 2003 Apr;37(4):862-70
references: 12668979